Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;111(4):700-703.
doi: 10.2105/AJPH.2020.306115. Epub 2021 Feb 18.

Seroprevalence of SARS-CoV-2 Antibodies in Rhode Island From a Statewide Random Sample

Philip A Chan  1 , Ewa King  1 , Yizhen Xu  1 , William Goedel  1 , Leanne Lasher  1 , Matt Vargas  1 , Ken Brindamour  1 , Richard Huard  1 , Ailis Clyne  1 , James McDonald  1 , Utpala Bandy  1 , David Yokum  1 , Michelle L Rogers  1 , Laura Chambers  1 , Siena C Napoleon  1 , Nicole Alexander-Scott  1 , Joseph W Hogan  1
Affiliations

Seroprevalence of SARS-CoV-2 Antibodies in Rhode Island From a Statewide Random Sample

Philip A Chan et al. Am J Public Health. 2021 Apr.

Abstract

Objectives. To characterize statewide seroprevalence and point prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Rhode Island.Methods. We conducted a cross-sectional survey of randomly selected households across Rhode Island in May 2020. Antibody-based and polymerase chain reaction (PCR)-based tests for SARS-CoV-2 were offered. Hispanics/Latinos and African Americans/Blacks were oversampled to ensure adequate representation. Seroprevalence estimations accounted for test sensitivity and specificity and were compared according to age, race/ethnicity, gender, housing environment, and transportation mode.Results. Overall, 1043 individuals from 554 households were tested (1032 antibody tests, 988 PCR tests). The estimated seroprevalence of SARS-CoV-2 antibodies was 2.1% (95% credible interval [CI] = 0.6, 4.1). Seroprevalence was 7.5% (95% CI = 1.3, 17.5) among Hispanics/Latinos, 3.8% (95% CI = 0.0, 15.0) among African Americans/Blacks, and 0.8% (95% CI = 0.0, 2.4) among non-Hispanic Whites. Overall PCR-based prevalence was 1.5% (95% CI = 0.5, 3.1).Conclusions. Rhode Island had low seroprevalence relative to other settings, but seroprevalence was substantially higher among African Americans/Blacks and Hispanics/Latinos. Rhode Island sits along the highly populated northeast corridor, making our findings broadly relevant to this region of the country. Continued monitoring via population-based sampling is needed to quantify these impacts going forward.

PubMed Disclaimer

References

    1. Havers FP, Reed C, Lim T et al. Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23–May 12, 2020. JAMA Intern Med. 2020 doi: 10.1001/jamainternmed.2020.4130. [Epub ahead of print]. - DOI - PubMed
    1. Sood N, Simon P, Ebner P et al. Seroprevalence of SARS-CoV-2-specific antibodies among adults in Los Angeles County, California, on April 10–11, 2020. JAMA. 2020;323(23):2425–2427. doi: 10.1001/jama.2020.8279. - DOI - PMC - PubMed
    1. Menachemi N. Population point prevalence of SARS-CoV-2 infection based on a statewide random sample—Indiana, April 25–29, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(29):960–964. doi: 10.15585/mmwr.mm6929e1. - DOI - PMC - PubMed
    1. Price-Haywood EG, Burton J, Fort D, Seoane L. Hospitalization and mortality among black patients and white patients with Covid-19. N Engl J Med. 2020;382(26):2534–2543. doi: 10.1056/NEJMsa2011686. - DOI - PMC - PubMed
    1. Tai DBG, Shah A, Doubeni CA, Sia IG, Wieland ML. The disproportionate impact of COVID-19 on racial and ethnic minorities in the United States. Clin Infect Dis . 2020 Jul 10;ciaa959. - DOI - PMC - PubMed